Search clinical trials for: Classic Hodgkin Lymphoma
Total 11206 results
-
Chinese PLA General HospitalNot yet recruitingPD-1 Inhibitor Failed Patients With Classical Hodgkin Lymphoma
-
Masonic Cancer Center, University of MinnesotaNot yet recruitingClassic Hodgkin Lymphoma | Autologous Stem Cell Transplant
-
National Cancer Institute (NCI)Not yet recruitingClassic Follicular Lymphoma | Follicular Lymphoma With Unusual Cytological Features
-
Navy General Hospital, BeijingRecruitingRefractory Classic Hodgkin Lymphoma | Relapsed Classic Hodgkin LymphomaChina
-
Shanghai Junshi Bioscience Co., Ltd.Recruiting
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingPembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin LymphomaClassic Hodgkin LymphomaUnited States
-
University of CologneNot yet recruitingHodgkin LymphomaGermany
-
GenmabRecruitingNon-Hodgkin Lymphoma | Classical Hodgkin LymphomaUnited States, Australia
-
Innolake BiopharmRecruitingMelanoma | Soft Tissue Sarcoma | Cervical Cancer | Head and Neck Cancer | Nasopharyngeal Carcinoma | Ovarian Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Classic Hodgkin LymphomaChina
-
Sun Yat-sen UniversityNot yet recruiting
-
Fondazione Italiana Linfomi - ETSNot yet recruitingClassical Hodgkin Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Diffuse Large B Cell Lymphoma (DLBCL)Italy
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; Seagen Inc.Recruiting
-
Sun Yat-sen UniversityGuangzhou Gloria Biosciences Co., Ltd.RecruitingClassical Hodgkin LymphomaChina
-
Chinese PLA General HospitalRecruitingRelapsed or Refractory Hodgkin LymphomaChina
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingSolid Tumor | Classic Hodgkin LymphomaChina
-
David Bond, MDRecruitingRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent... and other conditionsUnited States
-
Hospital Universitario Dr. Jose E. GonzalezRecruitingSafety Issues | Efficacy, SelfMexico
-
St. Petersburg State Pavlov Medical UniversityN.N. Petrov National Medical Research Center of OncologyRecruitingHodgkin LymphomaRussian Federation
-
University of Milano BicoccaAzienda Ospedaliera Universitaria Integrata Verona; Azienda Socio Sanitaria... and other collaboratorsRecruitingCardiac Arrest | Status EpilepticusItaly
-
University of UtahIncyte CorporationRecruitingHodgkin LymphomaUnited States
-
NuCana plcRecruitingMelanoma | Renal Cell Carcinoma | Gastric Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Advanced Cancer | Head and Neck Squamous Cell Carcinoma | Endometrial Carcinoma | Urothelial Carcinoma | Classical Hodgkin Lymphoma | Neoplasm Malignant | Pleural... and other conditionsUnited Kingdom
-
Guangzhou Gloria Biosciences Co., Ltd.Not yet recruitingRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Classic Hodgkin's Lymphoma
-
Merck Sharp & Dohme LLCRecruitingHodgkin LymphomaAustralia, Israel, Korea, Republic of, Spain, Poland, Sweden, United Kingdom, Turkey, China, United States, Brazil, Germany, Belgium, France, Switzerland, Canada, Czechia, Chile, Argentina
-
GenmabAbbVieRecruitingDiffuse Large B-Cell Lymphoma | Classic Follicular LymphomaUnited States, Puerto Rico
-
University of VirginiaMerck Sharp & Dohme LLCRecruitingClassical Hodgkin LymphomaUnited States
-
MacroGenicsRecruitingMyelodysplastic Syndromes | Chronic Myeloid Leukemia | Classical Hodgkin Lymphoma | Blastic Plasmacytoid Dendritic Cell Neoplasm | Leukemia, B-cell | Leukemia, Hairy Cell | Leukemia, Acute Myeloid | Mastocytosis, Aggressive SystemicUnited States
-
National Cancer Center, KoreaRecruitingRelapsed/Refractory Classical Hodgkin LymphomaKorea, Republic of
-
AkesoPeking University Cancer Hospital & InstituteRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
Institute of Hematology & Blood Diseases HospitalRecruitingRefractory Hodgkin Lymphoma | Relapse | Hodgkin Lymphoma, AdultChina
-
Emory UniversityNational Cancer Institute (NCI)RecruitingRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
University of CologneNot yet recruitingClassical Hodgkin LymphomaGermany
-
University of CologneNot yet recruitingClassical Hodgkin LymphomaGermany
-
State Budgetary Healthcare Institution, National...RecruitingHodgkin Lymphoma, AdultRussian Federation
-
Sun Yat-sen UniversityRecruitingClassical Hodgkin Lymphoma | Refractory or Relapsed Classical Hodgkin LymphomaChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRelapsed Classic Hodgkin LymphomaUnited States
-
Chinese PLA General HospitalRecruitingHodgkin Lymphoma | Anti-PD-1 Antibody ResistantChina
-
University Health Network, TorontoRecruitingClassical Hodgkin Lymphoma | Relapsed Cancer | Refractory CancerCanada
-
Chinese PLA General HospitalRecruiting
-
BeiGeneRecruitingClassical Hodgkin LymphomaChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingClassical Hodgkin LymphomaChina
-
Baylor College of MedicineThe Methodist Hospital Research InstituteRecruitingClassical Hodgkin Lymphoma | Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Eurofarma Laboratorios S.A.Recruiting
-
Chinese PLA General HospitalRecruiting
-
UNC Lineberger Comprehensive Cancer CenterAmerican Society of Clinical OncologyRecruitingRefractory Hodgkin Lymphoma | Relapsed Hodgkin LymphomaUnited States
-
Henan Cancer HospitalRecruitingClassical Hodgkin LymphomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
St. Jude Children's Research HospitalSeagen Inc.; Teva Pharmaceuticals USARecruiting
-
Veronika BachanovaBristol-Myers Squibb; Incyte CorporationRecruitingHodgkin LymphomaUnited States